Description: Hear diverse perspectives from both a reinsurer and carrier on how to best structure financial reinsurance transactions. Join us as we consider various ceding company objectives as well as impacts from the dynamic economic and regulatory environment. By attending this session, you will be able to: - Better understand common reinsurance transactions - Evaluate whether reinsurance transactions can help you meet your company's objectives and challenges - Gain an appreciation for the ever-changing economic and regulatory environment

Description: At the conclusion of the first part, attendees will be able to describe sources of reserve redundancy for products under Principle Based Reserve (PBR) and products under Commissioners' Annuity Reserve Valuation Method (CARVM). Such products include Term Life, Whole Life, Universal Life, and Fixed Annuity with and without rider. We will also review sources of capital redundancy from the C-1 factor under Risk-Based Capital (RBC) and assets such as Unrated Asset Credit Fund can have high C-1 factor even if its risks are limited. At the conclusion of the second part, the attendees will learn about potential Reserve Relief reinsurance solutions. Such solutions can provide Reserve Relief for annuity and term life businesses, as well as potential innovative asset-side solutions. Asset managers can structure assets that the C-1 factor aligned with the corresponding risk.

Description: Value of new business (VNB) is being used by many companies for various purposes including: internal and external financial reporting, incentive compensation, pricing, capital management, and comparing products, distribution channels or regions on a consistent basis. Presenters will discuss how and why value of new business is used within their companies including: the various methodologies considered, some of the benefits and challenges related to implementing VNB, integrating VNB within their business as usual processes, and managing to VNB.

Description: In recent years, there has been a significant increase in life and annuity business transactions transferring blocks of business across jurisdictions. These transactions raise important questions for stakeholders-including policyholders, regulators, rating agencies, investors, and companies themselves-about the drivers of financial results under different regulatory and accounting regimes.As financial reporting frameworks grow more complex-whether US Statutory, IFRS 17, US GAAP, or Solvency II-stakeholders are demanding deeper insights into how results are determined and how they compare across jurisdictions. Understanding these differences is critical for assessing financial performance, capital strength, and risk exposures, particularly in a cross-border context.To address this need, many companies are developing and applying bridging analyses-such as waterfall analyses, step-by-step reconciliations, and other frameworks-to explain how and why results differ between reporting bases. These approaches help clarify key drivers and provide transparency to stakeholders.In this session, representatives from leading companies will share practical approaches they use to bridge these gaps, offering insights into the methodologies and analyses that have proven most effective in navigating cross-jurisdiction financial reporting challenges. Attendees will gain a clearer understanding of cross-jurisdiction reporting differences and take away ideas for applying effective bridging techniques within their own organizations.

Description: "Asset-intensive reinsurance has become a focal point of actuarial, administrative and regulatory consideration in recent years. This session will walk through a real-world reinsurance case study of an illustrative transaction - from the initial actuarial due diligence process of the cedant's subject business through onboarding and integrating that business into the reinsurer's platform. Topics will include actuarial due diligence, experience studies and assumption setting, model validation, model development and onboarding of the subject business. The session aims to provide a variety of insights into this process across different business units and functions. By the end of the session, attendees will have a firm understanding of key transaction-related topics within the context of a real-world example."

Description: Under long-duration targeted improvements (LDTI), there are a few insurance liability balances that now are required to be fair valued, market risk benefit (MRB). The session will start from all the applicable balances that are required to be fair valued under LDTI ((i.e., MRB, financial accounting statement (FAS) 133, value of business acquired (VOBA) upon business combination)). The session will use a case study to discuss some of the nuances and general considerations for an MRB, FAS 133 and VOBA balances for a business combination for an fixed indexed annuity (FIA) contract. The case study will discuss some MRB fair value considerations and followed by FAS 133 fair value techniques. It will go over VOBA fair value estimation by using actuarial appraisal method with a few twists (e.g., using market yield in generating distributable earnings is better than using book yield and adjusted to bring it to fair value later on).

Description: By attending the session, you will learn: - Different perspectives around what FP&A is used for (e.g., strategic planning, performance measurement, management compensation, liquidity management, etc.) and why - Challenges leaders have faced and how they are being addressing - How recent regulatory, accounting, and technological change has impacted the FP&A function - Objectives for various organizations around both new analytics for business management, efficient production of forecast results, and potential for faster 'top down' forecasting

Description: Value of new business (VNB) is being used by many companies for various purposes including: internal and external financial reporting, incentive compensation, pricing, capital management, and comparing products, distribution channels or regions on a consistent basis. Presenters will discuss how and why value of new business is used within their companies including: the various methodologies considered, some of the benefits and challenges related to implementing VNB, integrating VNB within their business as usual processes, and managing to VNB.

Description: This session will cover the treatment of various forms of reinsurance under Valuation Manual-20 (VM-20). Speakers will discuss the implications of various types of reinsurance agreements on the calculation of principle-based reserves (PBR). This will include coinsurance and modified coinsurance, guaranteed and non-guaranteed yearly renewable term (YRT), as well as financial reinsurance.

Description: Indexed universal life (IUL) continues to be the most popular universal life (UL) product with sales reaching $1B in Q4 2023, according to LIMRA. There is little long-term experience for IUL and many companies value and model IUL just like UL, but there are material potential differences that need to be considered for valuation and projection purposes.